High Court OKs Patent Use Challenges By Generic Drug Cos.
The U.S. Supreme Court ruled Tuesday that a generic-drug maker can countersue to force a pharmaceutical patent-holder to correct a use code overstating a patent's scope, nixing an earlier decision in...To view the full article, register now.
Already a subscriber? Click here to view full article